eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Napp Pharmaceuticals Limited

Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0GW
Telephone: +44 (0)1223 424 444
Fax: +44 (0)1223 424 441
WWW: http://www.napp.co.uk
Medical Information Fax: +44 (0)1223 424 912

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 13/07/2011
PIL DepoCyte 50 mg suspension for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
Updated on 22/07/2010 and displayed until 13/07/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to MA holder contact details
Updated on 15/04/2009 and displayed until 22/07/2010
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 05/01/2009 and displayed until 15/04/2009
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to name of manufacturer
Updated on 26/10/2006 and displayed until 05/01/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to storage instructions
  • Change to drug interactions
  • Change to information about driving or using machinery
  • Change to Further Information section
  • Change to date of revision
Updated on 20/09/2004 and displayed until 26/10/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   cytarabine